-
Je něco špatně v tomto záznamu ?
Ruthenium(II) Complex Containing a Redox-Active Semiquinonate Ligand as a Potential Chemotherapeutic Agent: From Synthesis to In Vivo Studies
A. Notaro, A. Frei, R. Rubbiani, M. Jakubaszek, U. Basu, S. Koch, C. Mari, M. Dotou, O. Blacque, J. Gouyon, F. Bedioui, N. Rotthowe, RF. Winter, B. Goud, S. Ferrari, M. Tharaud, M. Řezáčová, J. Humajová, P. Tomšík, G. Gasser,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- chinony chemie metabolismus farmakologie MeSH
- HeLa buňky MeSH
- lidé MeSH
- ligandy MeSH
- myši nahé MeSH
- myši MeSH
- oxidace-redukce účinky léků MeSH
- protinádorové látky chemie metabolismus farmakologie MeSH
- ruthenium chemie metabolismus farmakologie MeSH
- viabilita buněk účinky léků fyziologie MeSH
- xenogenní modely - testy protinádorové aktivity metody MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- myši MeSH
- ženské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Chemotherapy remains one of the dominant treatments to cure cancer. However, due to the many inherent drawbacks, there is a search for new chemotherapeutic drugs. Many classes of compounds have been investigated over the years to discover new targets and synergistic mechanisms of action including multicellular targets. In this work, we designed a new chemotherapeutic drug candidate against cancer, namely, [Ru(DIP)2(sq)](PF6) (Ru-sq) (DIP = 4,7-diphenyl-1,10-phenanthroline; sq = semiquinonate ligand). The aim was to combine the great potential expressed by Ru(II) polypyridyl complexes and the singular redox and biological properties associated with the catecholate moiety. Experimental evidence (e.g., X-ray crystallography, electron paramagnetic resonance, electrochemistry) demonstrates that the semiquinonate is the preferred oxidation state of the dioxo ligand in this complex. The biological activity of Ru-sq was then scrutinized in vitro and in vivo, and the results highlight the promising potential of this complex as a chemotherapeutic agent against cancer.
Department of Chemistry University of Konstanz Universitätsstrasse 10 D 78457 Konstanz Germany
Department of Chemistry University of Zurich Winterthurerstrasse 190 8057 Zurich Switzerland
Institut Curie PSL University CNRS UMR 144 F 75005 Paris France
Université de Paris Institut de physique du Globe de Paris CNRS F 75005 Paris France
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20028149
- 003
- CZ-PrNML
- 005
- 20210114153105.0
- 007
- ta
- 008
- 210105s2020 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1021/acs.jmedchem.0c00431 $2 doi
- 035 __
- $a (PubMed)32319768
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Notaro, Anna $u Chimie ParisTech, PSL University, CNRS, Institute of Chemistry for Life and Health Sciences, Laboratory for Inorganic Chemical Biology, F-75005 Paris, France.
- 245 10
- $a Ruthenium(II) Complex Containing a Redox-Active Semiquinonate Ligand as a Potential Chemotherapeutic Agent: From Synthesis to In Vivo Studies / $c A. Notaro, A. Frei, R. Rubbiani, M. Jakubaszek, U. Basu, S. Koch, C. Mari, M. Dotou, O. Blacque, J. Gouyon, F. Bedioui, N. Rotthowe, RF. Winter, B. Goud, S. Ferrari, M. Tharaud, M. Řezáčová, J. Humajová, P. Tomšík, G. Gasser,
- 520 9_
- $a Chemotherapy remains one of the dominant treatments to cure cancer. However, due to the many inherent drawbacks, there is a search for new chemotherapeutic drugs. Many classes of compounds have been investigated over the years to discover new targets and synergistic mechanisms of action including multicellular targets. In this work, we designed a new chemotherapeutic drug candidate against cancer, namely, [Ru(DIP)2(sq)](PF6) (Ru-sq) (DIP = 4,7-diphenyl-1,10-phenanthroline; sq = semiquinonate ligand). The aim was to combine the great potential expressed by Ru(II) polypyridyl complexes and the singular redox and biological properties associated with the catecholate moiety. Experimental evidence (e.g., X-ray crystallography, electron paramagnetic resonance, electrochemistry) demonstrates that the semiquinonate is the preferred oxidation state of the dioxo ligand in this complex. The biological activity of Ru-sq was then scrutinized in vitro and in vivo, and the results highlight the promising potential of this complex as a chemotherapeutic agent against cancer.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a protinádorové látky $x chemie $x metabolismus $x farmakologie $7 D000970
- 650 _2
- $a viabilita buněk $x účinky léků $x fyziologie $7 D002470
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a HeLa buňky $7 D006367
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a ligandy $7 D008024
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a myši nahé $7 D008819
- 650 _2
- $a oxidace-redukce $x účinky léků $7 D010084
- 650 _2
- $a chinony $x chemie $x metabolismus $x farmakologie $7 D011809
- 650 _2
- $a ruthenium $x chemie $x metabolismus $x farmakologie $7 D012428
- 650 _2
- $a xenogenní modely - testy protinádorové aktivity $x metody $7 D023041
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Frei, Angelo $u Department of Chemistry, University of Zurich, Winterthurerstrasse 190, 8057 Zurich, Switzerland.
- 700 1_
- $a Rubbiani, Riccardo $u Department of Chemistry, University of Zurich, Winterthurerstrasse 190, 8057 Zurich, Switzerland.
- 700 1_
- $a Jakubaszek, Marta $u Chimie ParisTech, PSL University, CNRS, Institute of Chemistry for Life and Health Sciences, Laboratory for Inorganic Chemical Biology, F-75005 Paris, France. Institut Curie, PSL University, CNRS UMR 144, F-75005 Paris, France.
- 700 1_
- $a Basu, Uttara $u Chimie ParisTech, PSL University, CNRS, Institute of Chemistry for Life and Health Sciences, Laboratory for Inorganic Chemical Biology, F-75005 Paris, France.
- 700 1_
- $a Koch, Severin $u Department of Chemistry, University of Zurich, Winterthurerstrasse 190, 8057 Zurich, Switzerland.
- 700 1_
- $a Mari, Cristina $u Department of Chemistry, University of Zurich, Winterthurerstrasse 190, 8057 Zurich, Switzerland.
- 700 1_
- $a Dotou, Mazzarine $u Chimie ParisTech, PSL University, CNRS, Institute of Chemistry for Life and Health Sciences, Laboratory for Inorganic Chemical Biology, F-75005 Paris, France.
- 700 1_
- $a Blacque, Olivier $u Department of Chemistry, University of Zurich, Winterthurerstrasse 190, 8057 Zurich, Switzerland.
- 700 1_
- $a Gouyon, Jérémie $u Chimie ParisTech, PSL University, CNRS, Institute of Chemistry for Life and Health Sciences, Team Synthèse, Electrochimie, Imagerie et Systèmes Analytiques pour le Diagnostic, F-75005 Paris, France.
- 700 1_
- $a Bedioui, Fethi $u Chimie ParisTech, PSL University, CNRS, Institute of Chemistry for Life and Health Sciences, Team Synthèse, Electrochimie, Imagerie et Systèmes Analytiques pour le Diagnostic, F-75005 Paris, France.
- 700 1_
- $a Rotthowe, Nils $u Department of Chemistry, University of Konstanz, Universitätsstrasse 10, D-78457 Konstanz, Germany.
- 700 1_
- $a Winter, Rainer F $u Department of Chemistry, University of Konstanz, Universitätsstrasse 10, D-78457 Konstanz, Germany.
- 700 1_
- $a Goud, Bruno $u Institut Curie, PSL University, CNRS UMR 144, F-75005 Paris, France.
- 700 1_
- $a Ferrari, Stefano $u Institute of Molecular Cancer Research, University of Zurich, CH-8057 Zurich, Switzerland. Institute of Molecular Genetics of the Czech Academy of Sciences, Videnska 1083, 143 00 Prague, Czech Republic.
- 700 1_
- $a Tharaud, Mickaël $u Université de Paris, Institut de physique du Globe de Paris, CNRS, F-75005 Paris, France.
- 700 1_
- $a Řezáčová, Martina $u Department of Medical Biochemistry, Faculty of Medicine in Hradec Kralove, Charles University, Šimkova 870, 500 03 Hradec Kralove, Czech Republic.
- 700 1_
- $a Humajová, Jana $u Institute of Biophysics and Informatics, First Faculty of Medicine, Charles University in Prague, 150 06 Prague, Czech Republic.
- 700 1_
- $a Tomšík, Pavel $u Department of Medical Biochemistry, Faculty of Medicine in Hradec Kralove, Charles University, Šimkova 870, 500 03 Hradec Kralove, Czech Republic.
- 700 1_
- $a Gasser, Gilles $u Chimie ParisTech, PSL University, CNRS, Institute of Chemistry for Life and Health Sciences, Laboratory for Inorganic Chemical Biology, F-75005 Paris, France.
- 773 0_
- $w MED00010049 $t Journal of medicinal chemistry $x 1520-4804 $g Roč. 63, č. 10 (2020), s. 5568-5584
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32319768 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20210105 $b ABA008
- 991 __
- $a 20210114153102 $b ABA008
- 999 __
- $a ok $b bmc $g 1608484 $s 1119329
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 63 $c 10 $d 5568-5584 $e 20200507 $i 1520-4804 $m Journal of medicinal chemistry $n J Med Chem $x MED00010049
- LZP __
- $a Pubmed-20210105